nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—FYN—Netrin mediated repulsion signals—DCC—ureter cancer	0.0352	0.0791	CbGpPWpGaD
Dasatinib—MAPK14—DSCAM interactions—DCC—ureter cancer	0.0314	0.0705	CbGpPWpGaD
Dasatinib—FMO3—urine—ureter cancer	0.027	0.0486	CbGeAlD
Dasatinib—FYN—DCC mediated attractive signaling—DCC—ureter cancer	0.0269	0.0604	CbGpPWpGaD
Dasatinib—SRC—Netrin mediated repulsion signals—DCC—ureter cancer	0.026	0.0583	CbGpPWpGaD
Dasatinib—TESK1—Cell-Cell communication—DCC—ureter cancer	0.0226	0.0506	CbGpPWpGaD
Dasatinib—MYT1—Integrated Pancreatic Cancer Pathway—DCC—ureter cancer	0.0219	0.0491	CbGpPWpGaD
Dasatinib—SRC—DCC mediated attractive signaling—DCC—ureter cancer	0.0198	0.0445	CbGpPWpGaD
Dasatinib—YES1—Netrin-mediated signaling events—DCC—ureter cancer	0.0189	0.0425	CbGpPWpGaD
Dasatinib—BMX—Apoptosis—DCC—ureter cancer	0.0179	0.0402	CbGpPWpGaD
Dasatinib—EPHB1—renal system—ureter cancer	0.0164	0.0296	CbGeAlD
Dasatinib—EPHB1—kidney—ureter cancer	0.0159	0.0287	CbGeAlD
Dasatinib—SIK2—renal system—ureter cancer	0.0145	0.0262	CbGeAlD
Dasatinib—FRK—renal system—ureter cancer	0.0142	0.0255	CbGeAlD
Dasatinib—FYN—Netrin-mediated signaling events—DCC—ureter cancer	0.0139	0.0312	CbGpPWpGaD
Dasatinib—BMX—urethra—ureter cancer	0.0136	0.0245	CbGeAlD
Dasatinib—SRMS—renal system—ureter cancer	0.0132	0.0238	CbGeAlD
Dasatinib—PTK6—renal system—ureter cancer	0.0129	0.0233	CbGeAlD
Dasatinib—SRMS—kidney—ureter cancer	0.0128	0.023	CbGeAlD
Dasatinib—PTK6—urethra—ureter cancer	0.0127	0.0229	CbGeAlD
Dasatinib—STAT5B—renal system—ureter cancer	0.0122	0.0221	CbGeAlD
Dasatinib—STAT5B—urethra—ureter cancer	0.012	0.0217	CbGeAlD
Dasatinib—STAT5B—kidney—ureter cancer	0.0118	0.0213	CbGeAlD
Dasatinib—FYN—Netrin-1 signaling—DCC—ureter cancer	0.0112	0.0251	CbGpPWpGaD
Dasatinib—EPHB1—Axon guidance—DCC—ureter cancer	0.0104	0.0233	CbGpPWpGaD
Dasatinib—SRC—Netrin-mediated signaling events—DCC—ureter cancer	0.0102	0.023	CbGpPWpGaD
Dasatinib—ZAK—urethra—ureter cancer	0.0101	0.0181	CbGeAlD
Dasatinib—CYP1A2—urine—ureter cancer	0.00973	0.0175	CbGeAlD
Dasatinib—TESK1—renal system—ureter cancer	0.00905	0.0163	CbGeAlD
Dasatinib—TESK1—urethra—ureter cancer	0.00889	0.016	CbGeAlD
Dasatinib—STK36—urethra—ureter cancer	0.00875	0.0158	CbGeAlD
Dasatinib—EPHB3—urethra—ureter cancer	0.00875	0.0158	CbGeAlD
Dasatinib—CSK—renal system—ureter cancer	0.00829	0.0149	CbGeAlD
Dasatinib—SRC—Netrin-1 signaling—DCC—ureter cancer	0.00823	0.0185	CbGpPWpGaD
Dasatinib—CSK—urethra—ureter cancer	0.00814	0.0147	CbGeAlD
Dasatinib—HCK—urethra—ureter cancer	0.00804	0.0145	CbGeAlD
Dasatinib—CSK—kidney—ureter cancer	0.00801	0.0144	CbGeAlD
Dasatinib—RIPK2—urethra—ureter cancer	0.00756	0.0136	CbGeAlD
Dasatinib—SIK1—renal system—ureter cancer	0.00751	0.0135	CbGeAlD
Dasatinib—EPHB1—Developmental Biology—DCC—ureter cancer	0.0074	0.0166	CbGpPWpGaD
Dasatinib—SIK1—urethra—ureter cancer	0.00738	0.0133	CbGeAlD
Dasatinib—ERBB3—renal system—ureter cancer	0.00736	0.0133	CbGeAlD
Dasatinib—EPHA4—urethra—ureter cancer	0.0073	0.0132	CbGeAlD
Dasatinib—SIK1—kidney—ureter cancer	0.00726	0.0131	CbGeAlD
Dasatinib—ERBB3—kidney—ureter cancer	0.00712	0.0128	CbGeAlD
Dasatinib—CYP3A4—urine—ureter cancer	0.00704	0.0127	CbGeAlD
Dasatinib—EPHB3—Axon guidance—DCC—ureter cancer	0.007	0.0157	CbGpPWpGaD
Dasatinib—MAPK14—renal system—ureter cancer	0.00686	0.0124	CbGeAlD
Dasatinib—FGR—urethra—ureter cancer	0.00671	0.0121	CbGeAlD
Dasatinib—LCK—urethra—ureter cancer	0.00671	0.0121	CbGeAlD
Dasatinib—MAPK14—kidney—ureter cancer	0.00663	0.012	CbGeAlD
Dasatinib—EPHB4—renal system—ureter cancer	0.0065	0.0117	CbGeAlD
Dasatinib—JAK2—renal system—ureter cancer	0.00645	0.0116	CbGeAlD
Dasatinib—EPHB4—urethra—ureter cancer	0.00638	0.0115	CbGeAlD
Dasatinib—FYN—renal system—ureter cancer	0.00637	0.0115	CbGeAlD
Dasatinib—JAK2—urethra—ureter cancer	0.00634	0.0114	CbGeAlD
Dasatinib—EPHB4—kidney—ureter cancer	0.00628	0.0113	CbGeAlD
Dasatinib—EPHA2—urethra—ureter cancer	0.00626	0.0113	CbGeAlD
Dasatinib—FYN—urethra—ureter cancer	0.00625	0.0113	CbGeAlD
Dasatinib—EPHA3—Axon guidance—DCC—ureter cancer	0.00624	0.014	CbGpPWpGaD
Dasatinib—ABL2—Axon guidance—DCC—ureter cancer	0.00624	0.014	CbGpPWpGaD
Dasatinib—EPHA5—Axon guidance—DCC—ureter cancer	0.00624	0.014	CbGpPWpGaD
Dasatinib—JAK2—kidney—ureter cancer	0.00624	0.0112	CbGeAlD
Dasatinib—FYN—kidney—ureter cancer	0.00615	0.0111	CbGeAlD
Dasatinib—MAP4K5—urethra—ureter cancer	0.00611	0.011	CbGeAlD
Dasatinib—MAP3K3—urethra—ureter cancer	0.00611	0.011	CbGeAlD
Dasatinib—EPHA8—Axon guidance—DCC—ureter cancer	0.00602	0.0135	CbGpPWpGaD
Dasatinib—LIMK2—Axon guidance—DCC—ureter cancer	0.00595	0.0134	CbGpPWpGaD
Dasatinib—EPHB4—Axon guidance—DCC—ureter cancer	0.00595	0.0134	CbGpPWpGaD
Dasatinib—EPHA4—Axon guidance—DCC—ureter cancer	0.00595	0.0134	CbGpPWpGaD
Dasatinib—EPHB6—urethra—ureter cancer	0.00584	0.0105	CbGeAlD
Dasatinib—EPHB2—Axon guidance—DCC—ureter cancer	0.00576	0.0129	CbGpPWpGaD
Dasatinib—YES1—renal system—ureter cancer	0.00574	0.0104	CbGeAlD
Dasatinib—YES1—urethra—ureter cancer	0.00564	0.0102	CbGeAlD
Dasatinib—PDGFRA—renal system—ureter cancer	0.00564	0.0102	CbGeAlD
Dasatinib—EPHB6—Axon guidance—DCC—ureter cancer	0.0056	0.0126	CbGpPWpGaD
Dasatinib—YES1—kidney—ureter cancer	0.00555	0.01	CbGeAlD
Dasatinib—SRC—renal system—ureter cancer	0.00553	0.00996	CbGeAlD
Dasatinib—SRC—kidney—ureter cancer	0.00534	0.00963	CbGeAlD
Dasatinib—EPHB3—Developmental Biology—DCC—ureter cancer	0.005	0.0112	CbGpPWpGaD
Dasatinib—MAP2K5—urethra—ureter cancer	0.00499	0.009	CbGeAlD
Dasatinib—CSF1R—urethra—ureter cancer	0.00487	0.00879	CbGeAlD
Dasatinib—EPHA2—Axon guidance—DCC—ureter cancer	0.00485	0.0109	CbGpPWpGaD
Dasatinib—FYN—Cell-Cell communication—DCC—ureter cancer	0.00452	0.0102	CbGpPWpGaD
Dasatinib—KIT—renal system—ureter cancer	0.00451	0.00812	CbGeAlD
Dasatinib—ABL2—Developmental Biology—DCC—ureter cancer	0.00445	0.01	CbGpPWpGaD
Dasatinib—EPHA5—Developmental Biology—DCC—ureter cancer	0.00445	0.01	CbGpPWpGaD
Dasatinib—EPHA3—Developmental Biology—DCC—ureter cancer	0.00445	0.01	CbGpPWpGaD
Dasatinib—KIT—urethra—ureter cancer	0.00443	0.00798	CbGeAlD
Dasatinib—PDGFRB—renal system—ureter cancer	0.0044	0.00793	CbGeAlD
Dasatinib—MAPK14—Cell-Cell communication—DCC—ureter cancer	0.00436	0.00978	CbGpPWpGaD
Dasatinib—KIT—kidney—ureter cancer	0.00436	0.00785	CbGeAlD
Dasatinib—PDGFRB—urethra—ureter cancer	0.00432	0.00779	CbGeAlD
Dasatinib—EPHA8—Developmental Biology—DCC—ureter cancer	0.0043	0.00965	CbGpPWpGaD
Dasatinib—PDGFRB—kidney—ureter cancer	0.00425	0.00767	CbGeAlD
Dasatinib—EPHA4—Developmental Biology—DCC—ureter cancer	0.00425	0.00954	CbGpPWpGaD
Dasatinib—EPHB4—Developmental Biology—DCC—ureter cancer	0.00425	0.00954	CbGpPWpGaD
Dasatinib—LIMK2—Developmental Biology—DCC—ureter cancer	0.00425	0.00954	CbGpPWpGaD
Dasatinib—EPHB2—Developmental Biology—DCC—ureter cancer	0.00411	0.00924	CbGpPWpGaD
Dasatinib—EPHB6—Developmental Biology—DCC—ureter cancer	0.00399	0.00897	CbGpPWpGaD
Dasatinib—ABL1—renal system—ureter cancer	0.00392	0.00707	CbGeAlD
Dasatinib—ABL1—urethra—ureter cancer	0.00385	0.00695	CbGeAlD
Dasatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—DCC—ureter cancer	0.00383	0.0086	CbGpPWpGaD
Dasatinib—ABL1—kidney—ureter cancer	0.00379	0.00684	CbGeAlD
Dasatinib—EPHA2—Developmental Biology—DCC—ureter cancer	0.00346	0.00777	CbGpPWpGaD
Dasatinib—ABL1—Integrated Pancreatic Cancer Pathway—DCC—ureter cancer	0.00336	0.00755	CbGpPWpGaD
Dasatinib—SRC—Cell-Cell communication—DCC—ureter cancer	0.00333	0.00749	CbGpPWpGaD
Dasatinib—CYP1B1—renal system—ureter cancer	0.00332	0.00599	CbGeAlD
Dasatinib—CYP1B1—kidney—ureter cancer	0.00321	0.00579	CbGeAlD
Dasatinib—MAPK14—Integrated Pancreatic Cancer Pathway—DCC—ureter cancer	0.0032	0.00719	CbGpPWpGaD
Dasatinib—YES1—Axon guidance—DCC—ureter cancer	0.00297	0.00666	CbGpPWpGaD
Dasatinib—SRC—Integrated Pancreatic Cancer Pathway—DCC—ureter cancer	0.00245	0.0055	CbGpPWpGaD
Dasatinib—ABCG2—urethra—ureter cancer	0.00243	0.00438	CbGeAlD
Dasatinib—CYP1A2—renal system—ureter cancer	0.00238	0.00429	CbGeAlD
Dasatinib—CYP1A1—renal system—ureter cancer	0.00235	0.00423	CbGeAlD
Dasatinib—CYP1A1—urethra—ureter cancer	0.00231	0.00416	CbGeAlD
Dasatinib—CYP3A5—renal system—ureter cancer	0.0023	0.00414	CbGeAlD
Dasatinib—CYP1A1—kidney—ureter cancer	0.00227	0.00409	CbGeAlD
Dasatinib—CYP3A5—kidney—ureter cancer	0.00222	0.004	CbGeAlD
Dasatinib—LYN—Axon guidance—DCC—ureter cancer	0.00221	0.00497	CbGpPWpGaD
Dasatinib—ABL1—Axon guidance—DCC—ureter cancer	0.0022	0.00495	CbGpPWpGaD
Dasatinib—FYN—Axon guidance—DCC—ureter cancer	0.00218	0.00489	CbGpPWpGaD
Dasatinib—YES1—Developmental Biology—DCC—ureter cancer	0.00212	0.00476	CbGpPWpGaD
Dasatinib—JAK2—Axon guidance—DCC—ureter cancer	0.00207	0.00465	CbGpPWpGaD
Dasatinib—CYP3A4—renal system—ureter cancer	0.00172	0.00311	CbGeAlD
Dasatinib—CYP3A4—kidney—ureter cancer	0.00167	0.003	CbGeAlD
Dasatinib—SRC—Axon guidance—DCC—ureter cancer	0.00161	0.00361	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—DCC—ureter cancer	0.00158	0.00355	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—DCC—ureter cancer	0.00157	0.00353	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—DCC—ureter cancer	0.00155	0.00349	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—DCC—ureter cancer	0.0015	0.00336	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—DCC—ureter cancer	0.00148	0.00332	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—ureter cancer	0.00145	0.00326	CbGpPWpGaD
Dasatinib—ABCB1—renal system—ureter cancer	0.00122	0.0022	CbGeAlD
Dasatinib—ABCB1—urethra—ureter cancer	0.0012	0.00216	CbGeAlD
Dasatinib—ABCB1—kidney—ureter cancer	0.00118	0.00213	CbGeAlD
Dasatinib—SRC—Developmental Biology—DCC—ureter cancer	0.00115	0.00257	CbGpPWpGaD
